Helix BiopharmaHBP 
$0.935.00%24h
5.00%24h
Global rank17371
Market cap$180.46M
Change 7d9.57%
YTD Performance500.00%
SP500 benchmarkOutperform
P/E-31.13
P/S0
Revenue$0
Earnings-$4.66M
Dividend yield-
Main Sector
Healthcare
Helix Biopharma (HBP) Cash on Hand
HBP Cash on Hand in 2022: $598.90K
According to Helix Biopharma latest financial reports the cash on hand of HBP is $598.90K, an decrease of -75.15% to 2022. At the end of 2022 company had $2.41M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
HBP Cash on Hand History from 2019 to 2023
-
Value:-
HBP Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $598.90K | -75.15% |
| 2022 | $2.41M | -8.78% |
| 2021 | $2.64M | -15.82% |
| 2020 | $3.14M | 1955.83% |
| 2019 | $152.69K | - |
View the Top Cash on Hand Companies 
